A nanomedicine platform was developed by the self-assembly of a cleavable prodrug with a photosensitizer to treat pancreatic cancer, one of the leading causes of cancer-related deaths in the world.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2022) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: